论文部分内容阅读
目的:探讨改良老年疾病累计评分(MCIRS-G)对评估老年肺癌预后的价值。方法:汇总分析70岁以上肺癌62例临床资料,计算总分(TSC)、严重指数(SV)和合并症指数(CM),统计分析各参数的预后意义。结果:62例中位生存期为30.5个月,其中51例(82.3%)伴有合并症,TSC、CM、SV与年龄增长呈正相关,多因素分析显示TSC、CM、SV、临床分期影响患者预后。结论:MCIRS-G能够准确评估合并症对老年肺癌预后的影响。
Objective: To explore the value of Modified Cumulative Elderly Disease Score (MCIRS-G) in evaluating the prognosis of elderly lung cancer. Methods: The clinical data of 62 patients with lung cancer over the age of 70 were collected and analyzed. The total score (TSC), severity index (SV) and comorbidity index (CM) were calculated and the prognostic significance of each parameter was statistically analyzed. RESULTS: Sixty-two patients had a median survival of 30.5 months, of which 51 (82.3%) had comorbidities. TSC, CM, and SV were positively correlated with age. Multivariate analysis showed that TSC, CM, SV, Prognosis. Conclusion: MCIRS-G can accurately assess the impact of complications on the prognosis of elderly lung cancer.